(Q34554267)

3 August 2017

1 reference

title

HDL and arteriosclerosis: beyond reverse cholesterol transport (English)

1 reference

3 August 2017

Arnold von Eckardstein

object named as

Arnold von Eckardstein

6

1 reference

3 August 2017

Jerzy-Roch Nofer

1

1 reference

3 August 2017

Beate Kehrel

2

1 reference

3 August 2017

Manfred Fobker

3

1 reference

3 August 2017

Bodo Levkau

4

1 reference

3 August 2017

Gerd Assmann

5

1 reference

3 August 2017

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

161

1 reference

3 August 2017

1-16

1 reference

3 August 2017

1

1 reference

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein--the clinical implications of recent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Acceleration of reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Stimulation of proliferation in stationary primary cultures of monkey aortic smooth muscle cells Part 2. Effect of varying concentrations of hyperlipemic serum and low density lipoproteins of varying dietary fat origins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Growth-stimulating effect of lipoproteins on human arterial smooth-muscle cells and lung fibroblasts is due to apo B-containing lipoproteins, type LDL and VLDL, and requires LDL receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL3 stimulates multiple signaling pathways in human skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoproteins induce a rapid and transient release of Ca2+ in cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins stimulate mitogen-activated protein kinases in human skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Rapid purification and activity of apolipoprotein C1 on the proliferation of bovine vascular endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Proliferative effect of high density lipoprotein (HDL) and HDL fractions (HDL1,2, HDL3) on virus transformed lymphoblastoid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Endothelial cell functions. Relationship to atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Endothelial dysfunction and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Primary endothelial dysfunction: atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The atherogenic lipoprotein phenotype and vascular endothelial dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Protective effect of high density lipoprotein on endothelium-dependent vasodilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein and its apolipoproteins inhibit cytolytic activity of complement. Studies on the nature of inhibitory moiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Pharmacodynamic profile of prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Is the antiatherosclerotic potency of HDL modulated by the origin of HDL?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Differential influence of lipoproteins isolated from women and men on the activity of the PGI2 synthetase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Function and activation of NF-kappa B in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoproteins inhibit fibrinogen binding on adenosine diphosphate-activated monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Haemostatic function and cardiovascular death: early results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjö, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Effects of lipids and lipoproteins on thrombosis and rheology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Hypertriglyceridemia and regulation of fibrinolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Platelet interaction with high and low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The role of apoE in inhibitory effects of apoE-rich HDL on platelet function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Protein kinase C-dependent desensitization of HDL3-activated phospholipase C in human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Phosphatidylcholine breakdown in HDL3 stimulated platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Pertussis toxin sensitive G-protein coupling of HDL receptor to phospholipase C in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

HDL3 activates phospholipase D in normal but not in glycoprotein IIb/IIIa-deficient platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Specific Binding Sites on Human Blood Platelets for Plasma Lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Platelet HDL(3) binding sites are not related to integrin alpha(IIb)beta(3) (GPIIb-IIIa).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Mechanisms for regulating platelet high density lipoprotein type3 binding sites: evidence that binding sites are downregulated by a protein kinase C-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Antioxidants and atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidized LDL and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidized phospholipids and isoprostanes in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Structural and functional properties of natural and chemical variants of apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Glycation impairs high-density lipoprotein function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Reduced cholesterol efflux to mildly oxidized high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Paraoxonase Polymorphism (Gln192Arg) as a Determinant of the Response of Human Coronary Arteries to Serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins stimulate molecular weight 80K protein phosphorylation in human trophoblast cells: evidence for a protein kinase-C-dependent pathway in human placental lactogen release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

High density lipoproteins stimulate placental lactogen release and adenosine 3',5'-monophosphate (cAMP) production in human trophoblast cells: evidence for cAMP as a second messenger in human placental lactogen release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900651-7

10.1016/S0021-9150(01)00651-7

7 January 2021

Identifiers

DOI

1 reference

release_mx5ffmhebrdrtj3flbezen7jcy

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mx5ffmhebrdrtj3flbezen7jcy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference